v3.26.1
Note 13 - Shareholders' Equity
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Equity [Text Block]

13.

SHAREHOLDERS' EQUITY

 

Dividend Restrictions

 

The Company's ability to pay cash dividends is dependent on dividends paid to it by the Bank and limited by California corporation law. Under California law, the holders of common stock of the Company are entitled to receive dividends when and as declared by the Board of Directors, out of funds legally available, subject to certain restrictions. The California General Corporation Law permits a California corporation such as the Company to make a distribution to its shareholders if its retained earnings equal at least the amount of the proposed distribution or if after giving effect to the distribution, the value of the corporation’s assets exceed the amount of its liabilities plus the amount of shareholders preferences, if any, and certain other conditions are met.

 

Dividends from the Bank to the Company are restricted under California law to the lesser of the Bank's retained earnings or the Bank's net income for the latest three fiscal years, less dividends previously declared during that period, or, with the approval of the DFPI to the greater of the retained earnings of the Bank, the net income of the Bank for its last fiscal year, or the net income of the Bank for its current fiscal year. As of December 31, 2025, the maximum amount available for dividend distribution under this restriction was $64,247,000. The Company paid a quarterly cash dividend of $0.30 per share on November 17, 2025, August 15, 2025, May 15, 2025, and February 17, 2025, and a quarterly cash dividend of $0.27 per share on November 15, 2024, August 15, 2024, May 15, 2024, and February 15, 2024.

 

Earnings Per Share

 

Basic earnings per share is computed by dividing income available to common shareholders by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflects the potential dilution that could occur if securities or other contracts to issue common stock, such as stock options, result in the issuance of common stock which shares in the earnings of the Company. The treasury stock method has been applied to determine the dilutive effect of stock options in computing diluted earnings per share.

 

  

For the Year Ended December 31,

 

(In thousands, except per share data)

 

2025

  

2024

  

2023

 

Net Income:

            

Net income

 $29,617  $28,619  $29,776 

Earnings Per Share:

            

Basic earnings per share

 $4.60  $4.85  $5.08 

Diluted earnings per share

 $4.54  $4.80  $5.02 

Weighted Average Number of Shares Outstanding:

            

Basic shares

  6,440   5,895   5,863 

Effect of dilutive of stock options and restricted stock

  77   73   71 

Diluted shares

  6,517   5,968   5,934 

 

Shares of common stock issuable under stock options for which the exercise prices were greater than the average market prices were not included in the computation of diluted earnings per share due to their antidilutive effect. Stock options not included in the computation of diluted earnings per share, due to shares not being in the-money and having an antidilutive effect, were 0, 5,860 and 101,994 for the years ended December 31, 2025, 2024 and 2023, respectively.

 

Stock Options

       

In May 2022, the Company’s shareholders approved  the 2022 Equity Incentive Plan (the “2022 Plan”), which provides for the grant of up to 576,550 shares of common stock, including 126,550 shares that remained available for grant under the 2013 Stock Option Plan when the 2022 Plan was adopted. The 2022 Plan provides for the grant of incentive stock options, nonqualified stock options, stock appreciation rights, restricted stock, restricted stock units and other stock-based awards. The frequency, amount and terms of stock-based awards may be determined by the Board of Directors or its compensation committee, consistent with the terms and purposes of the 2022 plan.

 

In May 2013, the Company established the 2013 Stock Option Plan for which 131,847 shares of common stock are reserved. With the establishment of the Company’s 2022 Equity Incentive Plan, no further options may be issued under the 2013 Stock Option Plan, though options previously granted continue to be outstanding and governed by the plan.

 

During the years ended December 31, 2025, and December 31, 2024, 30,803 and 107,200 options, respectively were granted under the 2022 plan. There were no options granted during the year ended December 31, 2023, under the 2022 plan. There were no options granted during the years ended December 31, 2025, 2024, and 2023 under the 2013 plan.  

 

A summary of the activity within the 2013 Plan follows: 

          

Weighted

     
          

Average

     
      

Weighted

  

Remaining

     
      

Average

  

Contractual

     
      

Exercise

  

Term in

  

Intrinsic

 
  

Shares

  

Price

  

Years

  

Value

 

Options outstanding at January 1, 2023

  189,917  $21.14         

Options exercised

  (24,400) $18.59         

Options outstanding at December 31, 2023

  165,517  $21.52         

Options cancelled

  (1,600) $24.40         

Options exercised

  (32,070) $17.03         

Options outstanding at December 31, 2024

  131,847  $22.58         

Options cancelled

  (3,200) $22.19         

Options exercised

  (45,505) $22.64         

Options outstanding at December 31, 2025

  83,142  $22.56   1.2  $1,840,328 

Options exercisable at December 31, 2025

  83,142  $22.56   1.2  $1,840,328 
                 

 

A summary of the activity within the 2022 Plan follows:

  

Shares

  Weighted Average Exercise Price  Weighted Average Remaining Contractual Term in Years  

Intrinsic Value

 

Options outstanding at January 1, 2023

  117,200  $31.00         

Options cancelled

  (10,400) $31.00         

Options exercised

  (1,300) $31.00         

Options outstanding at December 31, 2023

  105,500  $31.00         

Options granted

  107,200  $34.07         

Options cancelled

  (1,200) $34.07         

Options exercised

  (1,300) $31.00         

Options outstanding at December 31, 2024

  210,200  $32.55         

Options granted

  30,803  $31.09         

Options cancelled

  (21,980) $32.41         

Options exercised

  (5,100) $31.36         

Options outstanding at December 31, 2025

  213,923  $32.38   7.2  $2,633,200 

Options exercisable at December 31, 2025

  100,278  $31.60   6.7  $1,312,809 

Expected to vest after December 31, 2025

  95,936  $33.16   7.6  $1,106,111 

 

 

 

Information related to the stock options plans during the twelve months ended December 31, 2025, and 2024.

  

2025

  

2024

 

Fair value of options vested

 $361,000  $199,000 

Intrinsic value of options exercised

 $1,087,000  $700,000 

Cash received from option exercises

 $1,105,000  $508,000 

Tax benefit from option exercises

 $93,000  $83,000 

Compensation cost

 $343,000  $393,000 

Tax benefit associated with compensation cost

 $23,000  $51,000 

 

As of December 31, 2025, there was $774 thousand of total unrecognized compensation cost related to non-vested, share-based compensation under the 2022 plan. That cost is expected to be recognized over a weighted average period of 3.0 years.  As of December 31, 2025, there was no unrecognized compensation cost related to non-vested, share-based compensation under the 2013 plan. 

 

Restricted Stock and Restricted Stock Units

 

During the twelve months ended December 31, 2024, the Company granted 3,033 restricted stock units with a fair value of $34.07 per share and a one-year vesting period. Compensation costs related to these units during the twelve months ended December 31, 2025 and 2024, were $14,000 and $89,000, respectively. As of December 31, 2025, there was no unrecognized compensation cost related to restricted stock units. 

 

During 2024 the Company granted 435 shares of restricted stock with a fair value of $46.04 per share and which fully vested on December 31, 2024, resulting in compensation costs during 2024 of $20,000. During 2022 the Company granted 1,650 shares of restricted stock with a fair value of $31 per share and a one-year vesting period. 825 of these shares were terminated during 2023 and 825 were fully vested on December 31, 2023. Compensation costs related to these shares during the twelve months ended December 2025, 2024, and 2023 totaled $0, $0, and $4,000, respectively. On  December 31, 2025, and 2024, there was no unrecognized compensation cost related to restricted stock.

 

Regulatory Capital

 

The Bank is subject to certain regulatory capital requirements administered by the FDIC. Failure to meet these minimum capital requirements can initiate certain mandatory and possibly additional discretionary, actions by regulators that, if undertaken, could have a direct material effect on the Company's consolidated financial statements. Under capital adequacy guidelines, the Bank must meet specific capital guidelines that involve quantitative measures of their assets, liabilities and certain off-balance sheet items as calculated under regulatory accounting practices. These quantitative measures are established by regulation and require that minimum amounts and ratios of total and Tier 1 capital to risk-weighted assets and of Tier 1 capital to average assets be maintained. Capital amounts and classifications are also subject to qualitative judgments by the regulators about components, risk weightings and other factors. 

 

The Bank is also subject to additional capital guidelines under the regulatory framework for prompt corrective action. To be categorized as well capitalized, the Bank must maintain total risk-based, Tier 1 risk-based and Tier 1 leverage ratios as set forth in the below table, and cannot be subject to a written agreement, order or capital directive issued by the FRB. 

 

In July 2013, the federal bank regulatory agencies adopted rules implementing the Basel Committee on Banking Supervision’s capital guidelines for U.S. banks, sometimes called “Basel III,” that increased the minimum regulatory capital requirements for bank holding companies and banks and implemented strict eligibility criteria for regulatory capital instruments. The Basel III capital rules include a minimum common equity Tier 1 ratio of 4.5%, a Tier 1 capital ratio of 6.0%, a total risk-based capital ratio of 8.0%, and a minimum leverage ratio of 4.0% (calculated as Tier 1 capital to average consolidated assets). The minimum capital levels required to be considered “well capitalized” include a common equity Tier 1 ratio of 6.5%, a Tier 1 risk-based capital ratio of 8.0%, a total risk-based capital ratio of 10.0% and a leverage ratio of 5.0%.  In addition, the Basel III capital rules require that banking organizations maintain “a capital conservation buffer” of 2.5% above the minimum capital requirements in order to avoid restrictions on their ability to pay dividends, repurchase stock or pay discretionary bonuses. Including the capital conservation buffer of 2.5%, the Basel III capital rules require the following minimum ratios for a bank holding company or bank to be considered well capitalized: a common equity Tier 1 capital ratio of 7.0%; a Tier 1 capital ratio of 8.5%, and a total capital ratio of 10.5%. At December 31, 2025, the Company’s and the Bank’s capital ratios exceed the thresholds necessary to be considered “well capitalized” under the Basel III framework.

 

Under the FRB’s Small Bank Holding Company and Savings and Loan Holding Company Policy Statement (the “Policy Statement”), qualifying bank holding companies with less than $3 billion in consolidated assets are exempt from the consolidated capital rules. The Company qualifies for treatment under the Policy Statement and is not currently subject to the Basel III consolidated capital rules at the bank holding company level. The new capital rules continue to apply to the Bank.

 

In 2019, the federal banking agencies issued a rule establishing a “community bank leverage ratio” (the ratio of a bank’s tier 1 capital to average total consolidated assets) that qualifying institutions with less than $10 billion in assets may elect to use in lieu of the generally applicable leverage and risk-based capital requirements under Basel III. A qualifying banking organization that elects to use the new ratio will be considered to have met all applicable federal regulatory capital and leverage requirements, including the minimum capital levels required to be considered “well capitalized,” if it maintains a community bank leverage ratio capital exceeding 9%.  The new rule became effective on January 1, 2020.  Plumas Bank has chosen not to opt into the community bank leverage ratio at this time.

 

 

 

The following table sets forth the Bank's actual capital amounts and ratios (dollar amounts in thousands):

          

Minimum Amount of Capital Required

 
                  

To be Well-Capitalized

 
          

For Capital

  

Under Prompt

 
  

Actual

  

Adequacy Purposes (1)

  

Corrective Provisions

 
  

Amount

  

Ratio

  

Amount

  

Ratio

  

Amount

  

Ratio

 

December 31, 2025

                        

Common Equity Tier 1 Ratio

 $247,747   14.8% $75,265   4.5% $108,717   6.5%

Tier 1 Leverage Ratio

  247,747   11.1%  89,237   4.0%  111,547   5.0%

Tier 1 Risk-Based Capital Ratio

  247,747   14.8%  100,354   6.0%  133,805   8.0%

Total Risk-Based Capital Ratio

  268,285   16.0%  133,805   8.0%  167,257   10.0%
                         

December 31, 2024

                        

Common Equity Tier 1 Ratio

 $199,308   17.3% $51,981   4.5% $75,084   6.5%

Tier 1 Leverage Ratio

  199,308   11.9%  66,856   4.0%  83,570   5.0%

Tier 1 Risk-Based Capital Ratio

  199,308   17.3%  69,308   6.0%  92,411   8.0%

Total Risk-Based Capital Ratio

  213,124   18.5%  92,411   8.0%  115,514   10.0%

 

     (1) Does not include amounts required under the capital conservation buffer discussed above.

 

The current and projected capital positions of the Company and the Bank and the impact of capital plans and long-term strategies are reviewed regularly by management. The Company policy is to maintain the Bank’s ratios above the prescribed well-capitalized ratios at all times. Management believes that the Bank currently meets all its capital adequacy requirements.